Skip to main content

Advertisement

SpringerLink
Log in

Concerns About Lung Cancer Among Prisoners

  • LUNG CANCER
  • Published:
Lung Aims and scope Submit manuscript

Abstract

Background

Few studies have looked at lung cancer in prisoners, despite this population is possibly at increased risk of malignancy. In a previous study, we found an early onset of lung cancer in prisoners. Thus, the present CARCAN study was aimed at assessing the epidemiological characteristics, management, prognosis, and incidence of lung cancer in prisoners compared to a sample of non-prisoner patients.

Method

We performed a multi-center observational case–control study. Cases were prisoners diagnosed with lung cancer from 2005 to 2013. Controls were non-prisoner lung cancer patients selected from hospital databases and randomly matched to cases (targeted case–control ratio: 1:3). Incidence rates in both groups were calculated using national statistics.

Results

Seventy-two cases and 170 controls met inclusion criteria. Cases were mainly men (99%). Mean age at diagnosis was 52.9 (± 11.0) in cases and 64.3 (± 10.1) in controls (p < 0.0001). More case patients were current smokers compared to control patients (83% vs 53%; p < 0.0001). We found no significant differences between the two groups as concerns histologic types, TNM stages at diagnosis, initially-employed treatments, times to management or survival. Incidence rates (2008–2012) in male prisoners were higher than those in the general population in all concerned age groups.

Conclusion

There is a shift of lung cancer toward young people in prisons. However, the presentation, management, and prognosis of lung cancer are similar between prisoners and non-prisoners. These finding could justify a specific screening policy for the incarcerated populations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Peto R, Darby S, Deo H, Silcocks P, Whitley E, Doll R (2000) Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ 321:323–329

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Couraud S, Zalcman G, Milleron B, Morin F, Souquet P-J (2012) Lung cancer in never smokers – a review. Eur J Cancer 48:1299–1311. https://doi.org/10.1016/j.ejca.2012.03.007

    Article  CAS  PubMed  Google Scholar 

  3. Brenner DR, McLaughlin JR, Hung RJ (2011) Previous lung diseases and lung cancer risk: a systematic review and meta-analysis. PLoS ONE 6:e17479. https://doi.org/10.1371/journal.pone.0017479

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Berthiller J, Straif K, Boniol M, Voirin N, Benhaïm-Luzon V, Ayoub WB et al (2008) Cannabis smoking and risk of lung cancer in men: a pooled analysis of three studies in Maghreb. J Thorac Oncol 3:1398–1403. https://doi.org/10.1097/JTO.0b013e31818ddcde

    Article  PubMed  Google Scholar 

  5. Sidorchuk A, Agardh EE, Aremu O, Hallqvist J, Allebeck P, Moradi T (2009) Socioeconomic differences in lung cancer incidence: a systematic review and meta-analysis. Cancer Causes Control 20:459. https://doi.org/10.1007/s10552-009-9300-8

    Article  PubMed  Google Scholar 

  6. Tardon A, Lee WJ, Delgado-Rodriguez M, Dosemeci M, Albanes D, Hoover R et al (2005) Leisure-time physical activity and lung cancer: a meta-analysis. Cancer Causes Control 16:389–397. https://doi.org/10.1007/s10552-004-5026-9

    Article  PubMed  PubMed Central  Google Scholar 

  7. Ministère de la Justice, France. Les chiffres clés de l’administration pénitentiaire au 1er janvier 2013. http://www.justice.gouv.fr/prison-et-reinsertion-10036/les-chiffres-clefs-10041/ladministration-penitentiaire-en-chiffres-25722.html

  8. Carbonnaux M, Fossard G, Amzallag E, Piegay C, Perot E, Chossegros P et al (2013) Earlier onset and poor prognosis of lung cancer in imprisoned patients. Oncology 85:370–377. https://doi.org/10.1159/000356877

    Article  CAS  PubMed  Google Scholar 

  9. Locher C, Debieuvre D, Coëtmeur D, Goupil F, Molinier O, Collon T et al (2013) Major changes in lung cancer over the last ten years in France: the KBP-CPHG studies. Lung Cancer 81:32–38. https://doi.org/10.1016/j.lungcan.2013.03.001

    Article  PubMed  Google Scholar 

  10. Urbaniak GC, Plous S (2013) Research randomizer (version 4.0). https://www.randomizer.org

  11. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383

    Article  CAS  PubMed  Google Scholar 

  12. de Decker L (2009) L’indice de co-morbidité de Charlson. Ann Gérontol 2:159–160. https://doi.org/10.1684/age.2009.0059

    Google Scholar 

  13. Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WEE et al (2016) The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. J Thorac Oncol 11:39–51. https://doi.org/10.1016/j.jtho.2015.09.009

    Article  PubMed  Google Scholar 

  14. Bouyer J, Hémon D, Cordier S, Derriennic F, Stücker I, Stengel B et al (2009) Epidémiologie: principes et méthodes quantitatives. INSERM, Paris. ISBN 978-2-7430-1167-3

  15. Ministère de la Justice, France. Séries statistiques des personnes placées sous main de justice. http://www.justice.gouv.fr/prison-et-reinsertion-10036/les-chiffres-clefs-10041/series-statistiques-des-personnes-placees-sous-main-de-justice-26147.html

  16. Binder-Foucard F, Belot A, Delafosse P, Remontet L, Woronoff A-S, Bossard N (2013) Estimation de l’incidence et de la mortalité par cancer en France métropolitaine entre 1980 et 2012. Partie 1 - Tumeurs solides. Institut de Veille Sanitaire, France. http://invs.santepubliquefrance.fr/Dossiers-thematiques/Maladies-chroniques-et-traumatismes/Cancers/Surveillance-epidemiologique-des-cancers/Estimations-de-l-incidence-de-la-mortalite-et-de-la-survie/Estimation-de-l-incidence-et-de-la-mortalite-par-cancer-en-France-metropolitaine-entre-1980-et-2012-Tumeurs-solides

  17. Institut National de la Statistique et des Etudes Economiques, France. Pyramides des âges - Bilan démographique. https://www.insee.fr/fr/statistiques/1913143?sommaire=1912926

  18. Baillargeon J, Black SA, Pulvino J, Dunn K (2000) The disease profile of Texas prison inmates. Ann Epidemiol 10:74–80

    Article  CAS  PubMed  Google Scholar 

  19. Rosen DL, Wohl DA, Schoenbach VJ (2011) All-cause and cause-specific mortality among black and white North Carolina State Prisoners, 1995–2005. Ann Epidemiol 21:719–726. https://doi.org/10.1016/j.annepidem.2011.04.007

    Article  PubMed  PubMed Central  Google Scholar 

  20. Mathew P, Elting L, Cooksley C, Owen S, Lin J (2005) Cancer in an incarcerated population. Cancer 104:2197–2204. https://doi.org/10.1002/cncr.21468

    Article  PubMed  Google Scholar 

  21. Davies EA, Sehgal A, Linklater KM, Heaps K, Moren C, Walford C et al (2010) Cancer in the London prison population, 1986-2005. J Public Health Oxf Engl 32:526–531. https://doi.org/10.1093/pubmed/fdq009

    Article  Google Scholar 

  22. Binswanger IA, Carson EA, Krueger PM, Mueller SR, Steiner JF, Sabol WJ (2014) Prison tobacco control policies and deaths from smoking in United States prisons: population based retrospective analysis. BMJ 349:g4542

    Article  PubMed  PubMed Central  Google Scholar 

  23. Institut National de la Statistique et des Etudes Economiques, France. Population par âge - Tableaux de l’Économie Française - Édition 2013. https://www.insee.fr/fr/statistiques/1374112?sommaire=1374192

  24. Institut national de prévention et d’éducation pour la santé (France), Beck F, Guilbert P, Gautier A (2007) Baromètre santé 2005: attitudes et comportements de santé. Éd. INPES, Saint-Denis

  25. Mouquet M-C (2005) La santé des personnes entrées en prison en 2003. Etudes et Résultats. http://drees.social-sante.gouv.fr/IMG/pdf/er386.pdf

  26. Cochet A, Isnard H (2007) Tuberculose dans les maisons d’arrêt en Île-de-France. Enquête prospective, 1er juillet 2005–30 juin 2006. Rapport dela Cire Ile-de-France et Institut de Veille Sanitaire. http://opac.invs.sante.fr/doc_num.php?explnum_id=3587

  27. Institut de Veille Sanitaire, France. Données épidémiologiques/Tuberculose/Maladies à déclaration obligatoire/Maladies infectieuses/Dossiers thématiques/Accueil. http://invs.santepubliquefrance.fr/Dossiers-thematiques/Maladies-infectieuses/Maladies-a-declaration-obligatoire/Tuberculose/Donnees-epidemiologiques

  28. Bryere J, Dejardin O, Launay L, Colonna M, Grosclaude P, Launoy G et al (2016) Socioeconomic status and site-specific cancer incidence, a Bayesian approach in a French Cancer Registries Network study. Eur J Cancer Prev Off J Eur Cancer Prev Organ ECP. https://doi.org/10.1097/CEJ.0000000000000326

    Google Scholar 

Download references

Acknowledgements

Authors thank M. Kevin Erwin for expert English rewording.

Funding

This study was supported by Grants from AGIRADOM and Chugai Pharma France. The sponsors had no role in the study.

Author information

Authors and Affiliations

  1. Faculté de Médecine Lyon Est, Université Lyon 1, 69008, Lyon, France

    Luc Renault

  2. Unité Hospitalière Sécurisée Interrégionale, Centre Hospitalier Lyon Sud, Institut de Cancérologie des Hospices Civils de Lyon, 69310, Pierre Bénite, France

    Emmanuel Perrot

  3. Département d’Information Médicale, Centre Hospitalier Lyon Sud, Institut de Cancérologie des Hospices Civils de Lyon, 69310, Pierre Bénite, France

    Eric Pradat

  4. UMR 7268 ADES, CNRS, EFS, Aix-Marseille Université, 13284, Marseille, France

    Christophe Bartoli

  5. Unité Hospitalière Sécurisée Interrégionale, Service de médecine en milieu pénitentiaire, Assistance Publique – Hôpitaux de Marseille, Hôpital Nord, 13015, Marseille, France

    Christophe Bartoli

  6. Service Oncologie multidisciplinaire et innovations thérapeutiques, Assistance Publique – Hôpitaux de Marseille, Hôpital Nord, 13015, Marseille, France

    Laurent Greillier

  7. Aix Marseille Université, 13284, Marseille, France

    Laurent Greillier

  8. Service d’Information Médicale, Assistance Publique – Hôpitaux de Marseille, Hôpital Nord, 13015, Marseille, France

    Anne Remacle-Bonnet

  9. Service de Médecine légale et pénitentiaire, Hôpital Rangueil, Centre Hospitalier Universitaire de Toulouse, 31059, Toulouse, France

    Norbert Telmon

  10. UMR 5288, CNRS, Faculté de Médecine Purpan, Université Toulouse III, 31000, Toulouse, France

    Norbert Telmon

  11. Service de pneumologie, Hôpital Larrey, Centre Hospitalier Universitaire de Toulouse, 31059, Toulouse, France

    Julien Mazières

  12. Université Toulouse III - Paul Sabatier, 31062, Toulouse, France

    Julien Mazières

  13. Département d’Information Médicale, Hôtel-Dieu Saint-Jacques, Centre Hospitalier Universitaire de Toulouse, 31059, Toulouse, France

    Laurent Molinier

  14. UMR 1027 INSERM - Université Toulouse III - Paul Sabatier, 31062, Toulouse, France

    Laurent Molinier

  15. Service de Pneumologie Aigue Spécialisée et Cancérologie Thoracique, Centre Hospitalier Lyon Sud, Institut de Cancérologie des Hospices Civils de Lyon, 165 chemin du grand Revoyet, 69310, Pierre Bénite, France

    Sébastien Couraud

  16. EMR3738 Ciblage thérapeutique en oncologie, Faculté de Médecine Lyon Sud-Charles Mérieux, Université Lyon 1, 69600, Oullins, France

    Sébastien Couraud

Authors
  1. Luc Renault
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Emmanuel Perrot
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eric Pradat
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Christophe Bartoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Laurent Greillier
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Anne Remacle-Bonnet
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Norbert Telmon
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Julien Mazières
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Laurent Molinier
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Sébastien Couraud
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sébastien Couraud.

Ethics declarations

Conflict of interest

Dr. MOLINIER reports grants, personal fees and non-financial support from SANOFI, personal fees and non-financial support from JANSSEN CILAG, personal fees from ABBVIE, personal fees from NESTLE, outside the submitted work. Dr. COURAUD reports grants from Chugai Pharma France, grants from AGIRADOM, during the conduct of the study; grants and non-financial support from BMS, grants, personal fees and non-financial support from Astra Zeneca, grants, personal fees and non-financial support from Pfizer, grants, personal fees, non-financial support and other from Roche, grants, personal fees, non-financial support and other from Chugai, personal fees and other from MSD, grants, personal fees, non-financial support and other from Boehringer Ingelheim, grants and non-financial support from Sysmex Innostics, grants, personal fees and non-financial support from Lilly, grants from Novartis, grants from Merck, grants and personal fees from Laidet Medical, grants and non-financial support from Amgen, outside the submitted work. Dr. GREILLIER reports grants, personal fees and non-financial support from ROCHE, personal fees and non-financial support from LILLY, grants and personal fees from NOVARTIS, personal fees and non-financial support from PFIZER, personal fees and non-financial support from BRISTOL-MYERS SQUIBB, personal fees and non-financial support from BOEHRINGER INGELHEIM, personal fees and non-financial support from ASTRA-ZENECA, outside the submitted work. Dr. RENAULT reports grants from Chugai Pharma France, grants from AGIRADOM, during the conduct of the study; non-financial support from Grünenthal, outside the submitted work. Other authors have nothing to disclose.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Renault, L., Perrot, E., Pradat, E. et al. Concerns About Lung Cancer Among Prisoners. Lung 196, 115–124 (2018). https://doi.org/10.1007/s00408-017-0066-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00408-017-0066-6

Keywords

Search

Navigation